4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-24-024899
Director sold 2,825 shares at $27.51 ($77,704)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Heyman Richard A. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-10-04 | Sale : show line 1 in the form 10b5-1 | −2,825 | $27.51 | $77,704 | 125,760 | D |
| Open-market sales · 2,825 sh · avg $27.51 · $77,704 | ||||||
Loading xslF345X05/form4-10082024_101045.xml…